Neutralization of pyrogen-induced tumour necrosis factor by its type 1 soluble receptor in guinea-pigs: Effects on fever and interleukin-6 release

Journal of Physiology

Volumn 509, Issue 1, 1998, Pages 267-275

  Roth, Joachim ^a   Martin, Dave ^b   Störr, Birgit ^a   Zeisberger, Eugen ^a  

^a UNIVERSITY HOSPITAL GIESSEN   (Germany)

^b AMGEN INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 6; LIPOPOLYSACCHARIDE; MURAMYL DIPEPTIDE; PYROGEN; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR RECEPTOR; BACTERIUM LIPOPOLYSACCHARIDE; MACROGOL; SOLUBLE TUMOR NECROSIS FACTOR RECEPTOR 1; SOLVENT; TUMOR NECROSIS FACTOR BINDING PROTEIN; TUMOR NECROSIS FACTOR INHIBITOR; TUMOR NECROSIS FACTOR RECEPTOR 1; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD LEVEL; BODY TEMPERATURE; CONTROLLED STUDY; CYTOKINE RELEASE; FEVER; GUINEA PIG; MALE; NONHUMAN; PRIORITY JOURNAL; ANIMAL TISSUE; ASSAY; CIRCULATION; LIMIT OF DETECTION;

ACETYLMURAMYL-ALANYL-ISOGLUTAMINE; ANIMALS; BODY TEMPERATURE; FEVER; GUINEA PIGS; INTERLEUKIN-6; LIPOPOLYSACCHARIDES; MALE; PYROGENS; RECEPTORS, TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0032523892     PISSN: 00223751     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1469-7793.1998.267bo.x     Document Type: Article

References (33)

1. AARDEN, L. A., DEGROOT, E. R., SCHAAP, O. L. & LANDSDORP, P. M. (1987). Production of hybridoma growth factors by human monocytes. European Journal of Immunology 17, 1411-1416.
2. BLATTEIS, C. M. & SEHIC, E. (1997). Fever: How may circulating pyrogens signal the brain? News in Physiological Sciences 12, 1-9.
3. COOPER, A. L., BROUWNER, S., TURNBULL, A. V., LUHESHI, G. N., HOPKINS, S. J., KUNKEL, S. L. & ROTHWELL, N. J. (1994). Tumor necrosis factor-α and fever after peripheral inflammation in the rat. American Journal of Physiology 267, R1431-1436.
4. DANTZER, R. (1994). How do cytokines say hello to the brain? Neural versus humoral mediation. European Cytokine Network 5, 271-273.
5. DINARELLO, C. A. (1994). The interleukin-1 family: 10 years of discovery. FASEB Journal 8, 1314-1325.
6. DINARELLO, C. A., CANNON, J. G., WOLFF, S. M., BERNHEIM, H. A., BEUTLER, B., CERAMI, A., FIGARI, J. S., PALLADINO, M. A. & O'CONNOR, J. V. (1986). Tumor necrosis factor (cachectin) is an endogenous pyrogen and induces production of interleukin 1. Journal of Experimental Medicine 163, 1433-1450.
7. ESPEVIC, T. & NISSEN-MEYER, J. (1986). A highly sensitive cell line, WEHI 164 clone 13, for measuring cytotoxic factor/tumor necrosis factor from human monocytes. Journal of Immunological Methods 95, 99-105.
8. EVANS, T. J., MOYES, D., CARPENTER, A., MARTIN, R., LOETSCHER, H., LESSLAUER, W. & COHEN, J. (1994). Protective effect of 55-but not 75 kD soluble tumor necrosis factor receptor-immunoglobulin G fusion proteins in an animal model of gramnegative sepsis. Journal of Experimental Medicine 180, 2173-2179.
9. GOLDBACH, J. M., ROTH, J., STÖRR, B. & ZEISBERGER, E. (1997a). Influence of pentoxifylline on fevers induced by bacterial lipopolysaccharide and tumor necrosis factor-α in guinea-pigs. European Journal of Pharmacology 319, 273-278.
10. GOLDBACH, J. M., ROTH, J. & ZEISBERGER, E. (1997b). Fever suppression by subdiaphragmatic vagotomy in guinea-pigs depends on the route of pyrogen administration. American Journal of Physiology 272, R675-681.
11. HOLT, I., COOPER, R. G. & HOPKINS, S. J. (1991). Relationship between local inflammation, interleukin-6 concentration and the acute phase response in arthritic patients. European Journal of Clinical Investigation 21, 479-484.
12. JANSKY, L., VYBIRAL, S., POSPISILOVA, D., ROTH, J., DORNAND, J., ZEISBERGER, E. & KAMINKOVA, J. (1995). Production of systemic and hypothalamic cytokines during the early phase of endotoxin fever. Neuroendocrinology 62, 55-61.
13. KAPAS, L., HONG, L., CADY, A. B., OPP, M. R., POSTLETHWAITE, A. E., SEYER, J. & KRUEGER, J. M. (1992). Somnogenic, pyrogenic, and anorectic activities of tumor necrosis factor-α and TNF-α fragments. American Journal of Physiology 263, R708-715.
14. KLIR, J. J., MCCLELLAN, J. L., KOZAK, W., SZELENYI, Z., WONG, G. H. W. & KLUGER, M. J. (1995). Systemic but not central administration of tumor necrosis factor-α attenuates LPS-induced fever in rats. American Journal of Physiology 268, R480-486.
15. KLUGER, M. J. (1991). Fever: role of pyrogens and cryogens. Physiological Reviews 71, 93-127.
16. KOZAK, W., CONN, C. A., KLIR, J. J., WONG, G. H. C. & KLUGER, M. J. (1995). TNF soluble receptor and antiserum against TNF enhance lipopolysaccharide fever in mice. American Journal of Physiology 269, R23-29.
17. LEMAY, L. G., VANDER, A. J. & KLUGER, M. J. (1990). The effects of pentoxifylline on lipopolysaccharide (LPS) fever, plasma interleukin 6 (IL 6), and tumor necrosis factor (TNF) in the rat. Cytokine 2, 300-306.
18. LEON, L. R., KOZAK, W., PESCHON, J. & KLUGER, M. J. (1997). Exacerbated febrile responses to LPS, but not turpentine, in TNF double receptor knockout mice. American Journal of Physiology 272, R563-569.
19. LONG, N. J., KUNKEL, S. L., VANDER, A. J. & KLUGER, M. J. (1990). Antiserum against tumor necrosis factor enhances lipopolysaccharide fever in rats. American Journal of Physiology 258, R332-337.
20. LUHESHI, G., MILLER, A. J., BROUWER, S., DASCOMBE, M. J., ROTHWELL, N. J. & HOPKINS, S. J. (1996). Interleukin-1 receptor antagonist inhibits endotoxin fever and systemic interleukin-6 induction in rats. American Journal of Physiology 270, E91-95.
21. MARTIN, D., NEAR, S. L., BENDELE, A. & RUSSELL, D. A. (1995). Inhibition of tumor necrosis factor is protective against neurologic dysfunction after active immunization of Lewis rats with myelin basic protein. Experimental Neurology 131, 221-228.
22. MICHIE, H. R., SPRIGGS, D. R., KANOGUE, K. R., SHERMAN, M. L., REVHAUG, A., O'DWYER, S., ARTHUR, K., DINARELLO, C. A., CERAMI, A., WOLFF, S. M., KUFED, D. W. & WILMORE, W. (1988). Tumor necrosis factor and endotoxin induce similar metabolic responses in human beings. Surgery 104, 280-286.
23. ROGY, M. A., COYLE, S. M., OLDENBURG, H. S. A., ROCK, C. S., BARIE, P. S., VAN ZEE, K. J., SMITH, C. G., MOLDAWER, L. L. & LOWRY, S. F. (1994). Persistently elevated soluble tumor necrosis factor receptor and interleukin-1 receptor antagonist levels in critically ill patients. Journal of the American College of Surgery 178, 132-138.
24. ROTH, J., CONN, C. A., KLUGER, M. J. & ZEISBERGKR, E. (1993). Kinetics of systemic and intrahypothalamic IL-6 and tumor necrosis factor during endotoxin fever in guinea-pigs. American Journal of Physiology 265, R653-65S.
25. ROTH, J., HOPKINS, S. J., HOADLEY, M. E., TRIPP, A., ASLAN, T., STÖRR, B., LUHESHI, G. N. & ZEISBERGER, E. (1997). Fever and production of cytokines in response to repeated injections of muramyl-dipeptide in guinea-pigs. Pflügers Archiv 434, 525-533.
26. ROTH, J., MCCLELLAN, J. L., KLUGER, M. J. & ZEISBERGER, E. (1994a). Attenuation of fever and release of cytokines after repeated injections of lipopolysaccharide in guinea-pigs. Journal of Physiology 477, 177-185.
27. ROTH, J., MCCLELLAN, J. L., KLUGER, M. J. & ZEISBERGER, E. (1994b). Changes in body temperature and circulating levels of interleukin-6 after intra-arterial injections or infusions of tumor necrosis factor α in guinea-pigs. Experientia 50, 815-820.
28. ROTHWELL, N. J. (1997). Neuroimmune interactions: the role of cytokines. British Journal of Pharmacology 121, 841-847.
29. SEHIC, E. & BLATTEIS, C. M. (1996). Blockade of lipopolysaccharide-induced fever by subdiaphragmatic vagotomy in guinea-pigs. Brain Research 726, 160-166.
30. STEFFERL, A., HOPKINS, S. J., ROTHWELL, N. J. & LUHESHI, G. N. (1996). The role of TNF-α in fever: opposing actions of human and murine TNF-α and interactions with IL-1β in the rat. British Journal of Pharmacology 118, 1919-1924.
31. TAKAHASHI, N., BROUCKAERT, R. & FIERS, W. (1995). Mechanism of tolerance to tumor necrosis factor: receptor specific pathway and selectivity. American Journal of Physiology 269, R398-405.
32. VAN ZEE K. J., KOHNO, T., FISCHER, E., ROCK, C. S., MOLDAWER, L. L. & LOWRY, S. F. (1992). Tumor necrosis factor soluble receptors circulate during experimental and clinical inflammation and can protect against excessive tumor necrosis factor α in vitro and in vivo. Proceedings of the National Academy of Sciences of the USA 88, 10535-10539.
33. WATKINS, L. R., MAIER, S. F. & GOEHLER, L. E. (1995). Cytokine-to-brain communication: a review and analysis of alternative mechanisms. Life Sciences 57, 1011-1026.